Cargando…

Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: Analysis of the HIV-2 Belgium and Luxembourg database

BACKGROUND: Guidelines established for the treatment of HIV-1 infection and genotype interpretation do not apply for HIV-2. Data about antiretroviral (ARV) drug efficacy and resistance mutations is scarce. METHODS: Clinical data about HIV-2 infected patients in Belgium and Luxembourg were collected...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ruelle, Jean, Roman, François, Vandenbroucke, Anne-Thérèse, Lambert, Christine, Fransen, Katrien, Echahidi, Fedoua, Piérard, Denis, Verhofstede, Chris, Van Laethem, Kristel, Delforge, Marie-Luce, Vaira, Dolorès, Schmit, Jean-Claude, Goubau, Patrick
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2292191/ https://www.ncbi.nlm.nih.gov/pubmed/18304321 http://dx.doi.org/10.1186/1471-2334-8-21

Ejemplares similares

Factors associated with the continuum of care of HIV-infected patients in Belgium
por: Van Beckhoven, Dominique, et al.
Publicado: (2014)

Decision tree for accurate infection timing in individuals newly diagnosed with HIV-1 infection
por: Verhofstede, Chris, et al.
Publicado: (2017)

HIV-1 low-level viraemia assessed with 3 commercial real-time PCR assays show high variability
por: Ruelle, Jean, et al.
Publicado: (2012)

Prevalence and Evolution of Transmitted Human Immunodeficiency Virus Drug Resistance in Belgium Between 2013 and 2019
por: Mortier, Virginie, et al.
Publicado: (2022)

Exploring HIV-1 Transmission Dynamics by Combining Phylogenetic Analysis and Infection Timing
por: Verhofstede, Chris, et al.
Publicado: (2019)

Polymorphisms of HIV-2 integrase and selection of resistance to raltegravir
por: Bercoff, Danielle Perez, et al.
Publicado: (2010)

Study of the HIV-2 Env Cytoplasmic Tail Variability and Its Impact on Tat, Rev and Nef
por: Bakouche, Nordine, et al.
Publicado: (2013)

Earlier Initiation of Antiretroviral Treatment Coincides With an Initial Control of the HIV-1 Sub-Subtype F1 Outbreak Among Men-Having-Sex-With-Men in Flanders, Belgium
por: Vinken, Lore, et al.
Publicado: (2019)

A21 HIV-1 sub-subtype F1 outbreak among MSM in Belgium
por: Vinken, L., et al.
Publicado: (2017)

Late presentation to HIV testing is overestimated when based on the consensus definition
por: Sasse, A, et al.
Publicado: (2015)

Validation of an ultrasensitive digital droplet PCR assay for HIV-2 plasma RNA quantification
por: Ruelle, Jean, et al.
Publicado: (2014)

Good continuum of HIV care in Belgium despite weaknesses in retention and linkage to care among migrants
por: Van Beckhoven, D., et al.
Publicado: (2015)

Enteroaggregative Shiga toxin-producing Escherichia coli of serotype O104:H4 in Belgium and Luxembourg
por: De Rauw, K, et al.
Publicado: (2014)

Single Amino Acid Substitution N659D in HIV-2 Envelope Glycoprotein (Env) Impairs Viral Release and Hampers BST-2 Antagonism
por: Dufrasne, François E., et al.
Publicado: (2016)

First evaluation of the Next-Generation Sequencing platform for the detection of HIV-1 drug resistance mutations in Belgium
por: Dessilly, Géraldine, et al.
Publicado: (2018)

Human immunodeficiency virus type 1 (HIV-1) proviral DNA load in purified CD4+ cells by LightCycler(® )Real-time PCR
por: Kabamba-Mukadi, Benoît, et al.
Publicado: (2005)

HIV-1 V3 envelope deep sequencing for clinical plasma specimens failing in phenotypic tropism assays
por: Vandenbroucke, Ina, et al.
Publicado: (2010)

Correction: First evaluation of the Next-Generation Sequencing platform for the detection of HIV-1 drug resistance mutations in Belgium
por: Dessilly, Géraldine, et al.
Publicado: (2019)

Comparison of phenotypic and genotypic tropism determination in triple-class-experienced HIV patients eligible for maraviroc treatment
por: Vandekerckhove, Linos, et al.
Publicado: (2011)

A hepatitis A, B, C and HIV prevalence and risk factor study in ever injecting and non-injecting drug users in Luxembourg associated with HAV and HBV immunisations
por: Removille, Nathalie, et al.
Publicado: (2011)

Characteristics and spread to the native population of HIV-1 non-B subtypes in two European countries with high migration rate
por: Dauwe, Kenny, et al.
Publicado: (2015)

Injection of cocaine is associated with a recent HIV outbreak in people who inject drugs in Luxembourg
por: Arendt, Vic, et al.
Publicado: (2019)

Short-term associations between Legionnaires' disease incidence and meteorological variables in Belgium, 2011–2019
por: Braeye, T., et al.
Publicado: (2020)

New insight in lymnaeid snails (Mollusca, Gastropoda) as intermediate hosts of Fasciola hepatica (Trematoda, Digenea) in Belgium and Luxembourg
por: Caron, Yannick, et al.
Publicado: (2014)

Effectiveness of antiretroviral therapy and development of drug resistance in HIV-1 infected patients in Mombasa, Kenya
por: Steegen, Kim, et al.
Publicado: (2009)

Quality Control of Next-Generation Sequencing-Based HIV-1 Drug Resistance Data in Clinical Laboratory Information Systems Framework
por: Capina, Rupert, et al.
Publicado: (2020)

Swab2know: An HIV-Testing Strategy Using Oral Fluid Samples and Online Communication of Test Results for Men Who Have Sex With Men in Belgium
por: Platteau, Tom, et al.
Publicado: (2015)

Persistence of frequently transmitted drug-resistant HIV-1 variants can be explained by high viral replication capacity
por: Pingen, Marieke, et al.
Publicado: (2014)

Predominance of the heterozygous CCR5 delta‐24 deletion in African individuals resistant to HIV infection might be related to a defect in CCR5 addressing at the cell surface
por: Arendt, Vic, et al.
Publicado: (2019)

Patterns of Transmitted HIV Drug Resistance in Europe Vary by Risk Group
por: Frentz, Dineke, et al.
Publicado: (2014)

Hypertension burden in Luxembourg: Individual risk factors and geographic variations, 2013 to 2015 European Health Examination Survey
por: Ruiz-Castell, Maria, et al.
Publicado: (2016)

International Symposium held at the Centre Universitaire de Luxembourg
por: Eymard, Pierre, et al.
Publicado: (1988)

Science Production in Germany, France, Belgium, and Luxembourg: Comparing the Contributions of Research Universities and Institutes to Science, Technology, Engineering, Mathematics, and Health
por: Powell, Justin J.W., et al.
Publicado: (2017)

Socio-economic, behavioural, (neuro)psychological and clinical determinants of HRQoL in people living with HIV in Belgium: a pilot study
por: Degroote, Sophie, et al.
Publicado: (2013)

Geographic Variations in Cardiometabolic Risk Factors in Luxembourg
por: Alkerwi, Ala’a, et al.
Publicado: (2017)

Estimating the individualized HIV-1 genetic barrier to resistance using a nelfinavir fitness landscape
por: Theys, Kristof, et al.
Publicado: (2010)

Genomics of an endemic cystic fibrosis Burkholderia multivorans strain reveals low within-patient evolution but high between-patient diversity
por: Lood, Cédric, et al.
Publicado: (2021)

Primary antibiotic resistance of Helicobacter pylori isolates is twofold more frequent in HIV‐positive than HIV‐negative individuals: A descriptive observational study
por: Nkuize, Marcel, et al.
Publicado: (2021)

Trends and Predictors of Transmitted Drug Resistance (TDR) and Clusters with TDR in a Local Belgian HIV-1 Epidemic
por: Pineda-Peña, Andrea-Clemencia, et al.
Publicado: (2014)

Cross-sectional survey evaluating blood pressure control ACHIEVEment in hypertensive patients treated with multiple anti-hypertensive agents in Belgium and Luxembourg
por: Leeman, Marc, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_9enqh3au2k0b89roqa8mq5rncv